Spread the love“`html 1. Understanding the Importance of High-Quality Audio In today’s digital age, the significance of high-quality audio cannot be overstated. Whether you’re a podcaster, musician, ...
PLUGIN WEEK 2026: Reverb is a hugely versatile tool that can be used to create all sorts of effects and transitions. Here, we ...
Palmier Pro is an open-source video editor that lets AI assistants like Claude organize, generate, and edit content directly inside a project timeline.
We tested Toggl Track, Timely, 7pace, QuickBooks Time, and ActivityWatch to find the best time-tracking tools for freelancers and remote teams.
All eyes will be on the Saratoga Race Course on Saturday, June 6 with the 158th running of the Belmont Stakes. Post time is 7:04 p.m. ET and while 2026 Preakness Stakes winner Napolean Solo will not ...
Researchers relied on a newer gene-editing technique that may make it possible to engineer embryos, a prospect that has long alarmed bioethicists. By Carl Zimmer Scientists at Columbia University have ...
The United States boasts a rich track and field history with many iconic figures. Track and field legend Jesse Owens persevered through racism and discrimination to win an unprecedented four gold ...
Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, as part of a study involving UCL scientists. Initial results from the ...
Cardiovascular diseases could be among the world’s first medical conditions to be treated by changing a patient’s genes. If ongoing phase 3 trials succeed, gene editing will offer a novel therapy for ...
Google launched a real-time streaming design agent and simultaneous multi-user collaboration for Stitch, its AI-native UI design tool, at I/O 2026 on May 20 — a direct challenge to Figma's position as ...
During last year's Preakness Stakes, the winner, Journalism, was the morning-line favorite before emerging victorious. Will we see the favorite win the 2026 Preakness Stakes? The 151st running is at ...
Intellia Therapeutics said its Crispr-based treatment for a rare swelling condition succeeded in a Phase 3 trial, a landmark for gene editing. The treatment uses Nobel Prize-winning Crispr technology ...